跳至主要内容
临床试验/CTRI/2025/09/094593
CTRI/2025/09/094593尚未招募Unknown

An Open Label, Single Arm Clinical Study to Evaluate the safety and efficacy of Sakriyam Pain Oil for the patients with Muscular pain

GHK PHARMACEUTICALS PRIVATE LIMITED1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年9月22日

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
1. Change in SGA score

研究概览

简要总结

An In-vivo study, Each participant entering the trial will be assigned to a regimen of investigational product, and advised to take general precautions as needed.

This study for 30 days in which Day 0 (Visit 1/Screening) done for screening purpose and handover the IP to the Subjects, and measure SGA, WOMAC, Musculoskeletal Health , VAS , EQ-5D-5L

The next visits- day 15, and day 30 involve WOMAC, VAS , EQ-5D-5L , Musculoskeletal Health Questionnaires.

Investigational Product: Sakriyam Pain Oil

Age criteria- 18 to 65 years

Test Product: Sakriyam Pain Oil, Dose**:** Apply oil two times a day, Route of Administration: Topical

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Subjects having Muscular pain.
  • Subjects from 18 to 65 years of age.
  • If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.
  • Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
  • Subjects willing to avoid participation in any other interventional clinical trial for the duration of the study.

排除标准

  • Subjects that are pregnant, breast feeding, or planning to get pregnant during the study.
  • Subjects that have participated in any other interventional clinical trial in the previous 30 days.
  • Subjects with known sensitivity to any of the constituents of the investigational product.

结局指标

主要结局

1. Change in SGA score

时间窗: Time Frame Day1, Day15 and Day30

2. Change in WOMAC score

时间窗: Time Frame Day1, Day15 and Day30

3. Change in Musculoskeletal Health score

时间窗: Time Frame Day1, Day15 and Day30

次要结局

  • 1. Change in VAS score(2. Change in EQ-5D-5L Score)

研究者

发起方
GHK PHARMACEUTICALS PRIVATE LIMITED
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Manoj Sharma

GS Ayurveda Medical College & Hospital Pilkhuwa Hapur

研究点 (1)

Loading locations...

相似试验